Evaluation of changes in cardiac biomarker concentrations and enzyme activities in serum after short- and long-duration transcutaneous cardiac pacing in dogs

American Journal of Veterinary Research

Volumn 70, Issue 5, 2009, Pages 599-603

  Lee, Seungkeun ^a   Pak, Son Il ^b   Hyun, Changbai ^b  

^a Korea Animal Hospital   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATINE KINASE; DILTIAZEM; ISOFLURANE; LACTATE DEHYDROGENASE; PROPOFOL; TROPONIN I;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; DOG; ELECTRODE; ENZYME ACTIVITY; FEMALE; HEART FUNCTION; HEART MUSCLE INJURY; HEART PACING; MALE; MUSCLE INJURY; NONHUMAN; PROTEIN BLOOD LEVEL; PULSE GENERATOR; SKELETAL MUSCLE; TREATMENT DURATION;

ANIMALS; BIOLOGICAL MARKERS; CARDIAC PACING, ARTIFICIAL; CREATINE KINASE, MB FORM; DOGS; ENZYMES; FEMALE; HEART; MALE; MYOCARDIUM; TIME FACTORS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TROPONIN I;

ANIMALIA; CANIS FAMILIARIS;

EID: 65749109052     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.70.5.599     Document Type: Article

References (15)

1. Bocka JJ. External pacemakers. Available at: emedicine.medscape.com/ article/780639-overview. Accessed Feb 5, 2008.
2. Kicklighter EJ, Syverud SA, Dalsey WC, et al. Pathological aspects of transcutaneous cardiac pacing. Am J Emerg Med 1985;3:108-113.
3. Madsen JK, Pedersen F, Grande P, et al. Normal myocardial enzymes and normal echocardiographic findings during noninvasive transcutaneous pacing. Pacing Clin Electrophysiol 1988;11:1188-1193.
4. Maisel AS, Blialla V, Braunwald E. Cardiac biomarkers: a contemporary status report (Erratum published in Nat Clin Pract Cardiovac Med 2006;3:288). Nat Clin Pract Cardiovasc Med 2006;3:24-34.
5. Syverud SA, Dalsey WC, Hedges JR, et al. Transcutaneous cardiac pacing: determination of myocardial injury in a canine model. Ann Emerg Med 1983;12:745-748.
6. Zoll PM, Zoll RH, Belgard AH. External noninvasive electric stimulation of the heart. Crit Care Med 1981;9:393-394.
7. Morrison LJ, Long J, Vermeulen M, et al. A randomized controlled feasibility trial comparing safety and effectiveness of prehospital pacing versus conventional treatment: 'PrePACE'. Resuscitation 2008;76:341-349.
8. Voorhees WD III, Foster KS, Geddes LA, et al. Safety factor for precordial pacing: minimum current thresholds for pacing and for ventricular fibrillation by vulnerable-period stimulation. Pacing Clin Electrophysiol 1984;7:356-360.
9. Lee SG, Moon HS, Hyun C. The efficacy and safety of external biphasic defibrillation in toy breed dogs. J Vet Emerg Crit Care 2008;18:362-369.
10. Pagani F, Stefini F, Micca G, et al. Multicenter evaluation of the TOSOH AIA-pack second-generation cardiac troponin I assay. Clin Chem 2004;50:1707-1709.
11. Archer J. Cardiac biomarker: a review. Comp Clin Pathol 2003;12:121-128.
12. Sadony V, Korber M, Albes G, et al. Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 1998;13:57-65.
13. Crowley LV. Creatine phosphokinase activity in myocardial infarction, heart failure, and following various diagnostic and therapeutic procedures. Clin Chem 1968;14:1185-1196.
14. Schober KE. Biochemical markers of cardiovascular disease. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 6th ed. St Louis: Elsevier Saunders, 2005;940-948.
15. Willard MD, Twedt DC. Gastrointestinal, pancreatic, and hepatic disorders. In: Willard MD, Tvedten H, eds. Small animal clinical diagnosis by laboratory methods. 4th ed. St Louis: Saunders, 2004;208-246.